The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Traveler’s Diarrhea Treatment Market Research Report 2025
Synopsis
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
The global Traveler’s Diarrhea Treatment market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1007.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Traveler’s Diarrhea Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler’s Diarrhea Treatment.
Report Scope
The Traveler’s Diarrhea Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Traveler’s Diarrhea Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler’s Diarrhea Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Traveler’s Diarrhea Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
The global Traveler’s Diarrhea Treatment market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1007.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Traveler’s Diarrhea Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler’s Diarrhea Treatment.
Report Scope
The Traveler’s Diarrhea Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Traveler’s Diarrhea Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler’s Diarrhea Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Traveler’s Diarrhea Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Traveler’s Diarrhea Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunization
1.2.3 Non-antibiotic Agents
1.2.4 Antibiotics
1.2.5 Anti-Motility Agents
1.2.6 Other
1.3 Market by Application
1.3.1 Global Traveler’s Diarrhea Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult Traveler's Diarrhea
1.3.3 Children Traveler's Diarrhea
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Traveler’s Diarrhea Treatment Market Perspective (2019-2030)
2.2 Traveler’s Diarrhea Treatment Growth Trends by Region
2.2.1 Global Traveler’s Diarrhea Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Traveler’s Diarrhea Treatment Historic Market Size by Region (2019-2024)
2.2.3 Traveler’s Diarrhea Treatment Forecasted Market Size by Region (2025-2030)
2.3 Traveler’s Diarrhea Treatment Market Dynamics
2.3.1 Traveler’s Diarrhea Treatment Industry Trends
2.3.2 Traveler’s Diarrhea Treatment Market Drivers
2.3.3 Traveler’s Diarrhea Treatment Market Challenges
2.3.4 Traveler’s Diarrhea Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Traveler’s Diarrhea Treatment Players by Revenue
3.1.1 Global Top Traveler’s Diarrhea Treatment Players by Revenue (2019-2024)
3.1.2 Global Traveler’s Diarrhea Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Traveler’s Diarrhea Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Traveler’s Diarrhea Treatment Revenue
3.4 Global Traveler’s Diarrhea Treatment Market Concentration Ratio
3.4.1 Global Traveler’s Diarrhea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Traveler’s Diarrhea Treatment Revenue in 2023
3.5 Traveler’s Diarrhea Treatment Key Players Head office and Area Served
3.6 Key Players Traveler’s Diarrhea Treatment Product Solution and Service
3.7 Date of Enter into Traveler’s Diarrhea Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Traveler’s Diarrhea Treatment Breakdown Data by Type
4.1 Global Traveler’s Diarrhea Treatment Historic Market Size by Type (2019-2024)
4.2 Global Traveler’s Diarrhea Treatment Forecasted Market Size by Type (2025-2030)
5 Traveler’s Diarrhea Treatment Breakdown Data by Application
5.1 Global Traveler’s Diarrhea Treatment Historic Market Size by Application (2019-2024)
5.2 Global Traveler’s Diarrhea Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Traveler’s Diarrhea Treatment Market Size (2019-2030)
6.2 North America Traveler’s Diarrhea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Traveler’s Diarrhea Treatment Market Size by Country (2019-2024)
6.4 North America Traveler’s Diarrhea Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Traveler’s Diarrhea Treatment Market Size (2019-2030)
7.2 Europe Traveler’s Diarrhea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Traveler’s Diarrhea Treatment Market Size by Country (2019-2024)
7.4 Europe Traveler’s Diarrhea Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Traveler’s Diarrhea Treatment Market Size (2019-2030)
8.2 Asia-Pacific Traveler’s Diarrhea Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Traveler’s Diarrhea Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Traveler’s Diarrhea Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Traveler’s Diarrhea Treatment Market Size (2019-2030)
9.2 Latin America Traveler’s Diarrhea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Traveler’s Diarrhea Treatment Market Size by Country (2019-2024)
9.4 Latin America Traveler’s Diarrhea Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Traveler’s Diarrhea Treatment Market Size (2019-2030)
10.2 Middle East & Africa Traveler’s Diarrhea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Traveler’s Diarrhea Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Traveler’s Diarrhea Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Salix Pharmaceuticals
11.1.1 Salix Pharmaceuticals Company Detail
11.1.2 Salix Pharmaceuticals Business Overview
11.1.3 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Introduction
11.1.4 Salix Pharmaceuticals Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.1.5 Salix Pharmaceuticals Recent Development
11.2 P&G
11.2.1 P&G Company Detail
11.2.2 P&G Business Overview
11.2.3 P&G Traveler’s Diarrhea Treatment Introduction
11.2.4 P&G Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.2.5 P&G Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Traveler’s Diarrhea Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Otsuka Pharma
11.4.1 Otsuka Pharma Company Detail
11.4.2 Otsuka Pharma Business Overview
11.4.3 Otsuka Pharma Traveler’s Diarrhea Treatment Introduction
11.4.4 Otsuka Pharma Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.4.5 Otsuka Pharma Recent Development
11.5 Valneva
11.5.1 Valneva Company Detail
11.5.2 Valneva Business Overview
11.5.3 Valneva Traveler’s Diarrhea Treatment Introduction
11.5.4 Valneva Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.5.5 Valneva Recent Development
11.6 Shanghai United Cell
11.6.1 Shanghai United Cell Company Detail
11.6.2 Shanghai United Cell Business Overview
11.6.3 Shanghai United Cell Traveler’s Diarrhea Treatment Introduction
11.6.4 Shanghai United Cell Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.6.5 Shanghai United Cell Recent Development
11.7 PaxVax
11.7.1 PaxVax Company Detail
11.7.2 PaxVax Business Overview
11.7.3 PaxVax Traveler’s Diarrhea Treatment Introduction
11.7.4 PaxVax Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.7.5 PaxVax Recent Development
11.8 Livzon
11.8.1 Livzon Company Detail
11.8.2 Livzon Business Overview
11.8.3 Livzon Traveler’s Diarrhea Treatment Introduction
11.8.4 Livzon Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.8.5 Livzon Recent Development
11.9 Immuron
11.9.1 Immuron Company Detail
11.9.2 Immuron Business Overview
11.9.3 Immuron Traveler’s Diarrhea Treatment Introduction
11.9.4 Immuron Revenue in Traveler’s Diarrhea Treatment Business (2019-2024)
11.9.5 Immuron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
